In response to the COVID-19 pandemic we at Johnston Martineau, LLP, are taking every precaution to insure the health and safety of our staff as well as our clients.
The majority of our staff are now working from home while we continue to provide excellent service to all new and existing clients.
At Johnston Martineau, LLP, we have taken steps to offer several alternate options for communication in lieu of actual in person meetings, you prefer to not be in public during this ongoing health concern.
As usual we can still meet in person at our office, or we can come to you at your home or preferred location. We are always available by phone at 515-493-4878 and we can also accommodate other forms of communication like email or if desired, we can facilitate a video “meeting” through ZOOM or Skype on your computer, tablet, or smartphone.
Schedule a Free Consultation Today! | No Fees if No Recovery | Se Habla Español.

IOWA ABILIFY PERSONAL INJURY ATTORNEY

Contact an Iowa Abilify Injury Lawyer today for a free consultation. We can be reached at 515-493-4878 or via email.

Capsules 13

Abilify (aripiprazole) is a heavily marketed and widely prescribed antipsychotic medication which has been approved for treatment of schizophrenia, bipolar disorder, and depression.

In fact, Abilify is one of the most frequently prescribed antipsychotic medications in the country. Shockingly, Abilify users have not been warned that compulsive gambling is one of the potential side effects of this drug.

Abilify works on the dopamine levels in the users brain which interferes with the pleasure seeking receptors. Although warnings are required in other countries, the United States does not require such a warning.

In October of 2012, Europe demanded an additional warning be added to Abilify due to the European Medicines Agency report showing a positive link between aripiprazole and possible pathological gambling. Health Canada also found a link between aripiprazole usage and a possible risk of pathological gambling.

Despite this knowledge, in the United States, Otsuka and Bristol Meyers Squibb have failed to provide a warning about Abilify and possible pathological gambling.

Fortunately, on May 3, 2016, the Food and Drug Administration (FDA) required that a warning be added to the Abilify label directing patients and caregivers to monitor experiences of uncontrollable behavior while taking Abilify. The warning also specifies that doctors must notify patients of these additional risks and ask patients about any new or increased urges they experience while taking Abilify.

Contact an Iowa personal injury lawyer today if you believe you have been injured by compulsive behavior brought on by Abilify.

Call us today at 515-493-4878 or contact us via email.

Client Review

“Brad is a great listener and very knowledgeable about his subject matter. Brad is very professional and has a positive demeanor.”
Libby Z.
Client Review